Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma.

被引:2
作者
Taylor, Matthew H.
Vogelzang, Nicholas J.
Cohn, Allen Lee
Stepan, Daniel E.
Shumaker, Robert Charles
Dutcus, Corina E.
Guo, Matthew
Schmidt, Emmett V.
Rasco, Drew W.
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Comprehens Canc Ctr Nevada, Las Vegas, NV USA
[3] US Oncol, Rocky Mt Canc Ctr, Denver, CO USA
[4] Eisai Inc, Woodcliff Lake, NJ USA
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] South Texas Accelerated Res Therapeut, San Antonio, TX USA
关键词
D O I
10.1200/JCO.2019.37.8_suppl.15
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
15
引用
收藏
页数:2
相关论文
共 50 条
[21]   Phase 3 study of first-line treatment with pembrolizumab plus belzutifan plus lenvatinib or pembrolizumab/quavonlimab plus lenvatinib versus pembrolizumab plus lenvatinib for advanced renal cell carcinoma (RCC). [J].
Choueiri, Toni K. ;
Plimack, Elizabeth R. ;
Powles, Thomas ;
Voss, Martin H. ;
Gurney, Howard ;
Silverman, Rachel Kloss ;
Perini, Rodolfo F. ;
Rodriguez-Lopez, Karla ;
Rini, Brian I. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[23]   A PHASE IB TRIAL OF ZIV-AFLIBERCEPT PLUS PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS [J].
Tyan, Kevin ;
Rahma, Osama ;
Giobbie-Hurder, Anita ;
Brohl, Andrew ;
Bedard, Philippe ;
Renouf, Daniel ;
Sharon, Elad ;
Streicher, Howard ;
Hathaway, Emma ;
Cunningham, Rachel ;
Manos, Michael ;
Severgnini, Mariano ;
Rodig, Scott ;
Hodi, F. Stephen .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 :A402-A404
[24]   Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer [J].
Van Le, Linda .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (05) :275-276
[25]   Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer [J].
Makker, V ;
Colombo, N. ;
Casado Herraez, A. ;
Santin, A. D. ;
Colomba, E. ;
Miller, D. S. ;
Fujiwara, K. ;
Pignata, S. ;
Baron-Hay, S. ;
Ray-Coquard, I ;
Shapira-Frommer, R. ;
Ushijima, K. ;
Sakata, J. ;
Yonemori, K. ;
Kim, Y. M. ;
Guerra, E. M. ;
Sanli, U. A. ;
McCormack, M. M. ;
Smith, A. D. ;
Keefe, S. ;
Bird, S. ;
Dutta, L. ;
Orlowski, R. J. ;
Lorusso, D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05) :437-448
[26]   Lenvatinib plus Pembrolizumab in advanced Endometrial Carcinoma [J].
Lorenz, Judith .
GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (05) :464-464
[27]   A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma [J].
Chen, Tom Wei-Wu ;
Hsu, Chia-Lang ;
Hong, Ruey-Long ;
Lee, Jen-Chieh ;
Chang, Koping ;
Yu, Chih-Wei ;
Chen, San-Chi ;
Guo, Jhe-Cyuan ;
Chen, Mei-Lu ;
Hsu, Meng-Chi ;
Kung, Ting-Fang ;
Cheng, Ann-Lii ;
Yen, Chueh-Chuan .
CLINICAL CANCER RESEARCH, 2022, 28 (23) :5058-5065
[28]   A phase Ib study of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC). [J].
Zhu, Andrew X. ;
Finn, Richard S. ;
Ikeda, Masafumi ;
Sung, Max W. ;
Baron, Ari David ;
Kudo, Masatoshi ;
Okusaka, Takuji ;
Kobayashi, Masahiro ;
Kumada, Hiromitsu ;
Kaneko, Shuichi ;
Pracht, Marc ;
Mamontov, Konstantin ;
Meyer, Tim ;
Mody, Kalgi ;
Kubota, Tomoki ;
Dutcus, Corina E. ;
Saito, Kenichi ;
Siegel, Abby B. ;
Dubrovsky, Leonid ;
Llovet, Josep M. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[29]   A phase I trial of panobinostat with ipilimumab in advanced melanoma. [J].
Khushalani, Nikhil I. ;
Markowitz, Joseph ;
Eroglu, Zeynep ;
Giuroiu, Iulia ;
Ladanova, Viktoriya ;
Reiersen, Pamela ;
Rich, Jeani ;
Thapa, Ram ;
Schell, Michael J. ;
Sotomayor, Eduardo M. ;
Weber, Jeffrey S. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[30]   S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma. [J].
Patel, Sapna Pradyuman ;
Othus, Megan ;
Moon, James ;
Tetzlaff, Michael T. ;
Buchbinder, Elizabeth Iannotti ;
Sondak, Vernon K. ;
Lowe, Michael C. ;
Campos, Danae ;
Sharon, Elad ;
Korde, Larissa A. ;
Carson, William Edgar ;
Ribas, Antoni ;
Grossmann, Kenneth F. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)